Fröscher W
Fortschr Neurol Psychiatr Grenzgeb. 1976 Mar;44(3):94-135.
The literature dealing with radiation myelopathy is reviewed. The following points are to be noticed:radiation myelopathy is a rare complication in the radiation therapy of extraspinal tumors, nevertheless the number of case reports is increasing during the last years; probably this is due to the increasing use of high energy therapy. Already a cord dose of 1000 rad may be dangerous; with an increasing dose the risk of radiation myelopathy is increasing too. Besides the total dose the incidence of radiation myelopathy depends on the rate of delivery, the over-all time of administration, the size of the individual fraction, the field size, the size of the volume irradiated, the type of irradiation, the use of hyperbaric oxygen and some other special conditions of radiation. But the incidence of radiation myelopathy depends not only on radiation technique but also on patients' variables. Individual variations in radiosensitivity are a well known fact; this may be partly due to an inherent biologic variation of response. Moreover the incidence of radiation myelopathy may be intensified by simultaneously existing diseases - above all by hypertension- and probably by some medicaments taken simultaneously. A dependence from age, sex, and the kind of the primary tumor seems not to exist. Radiation lesions of the cervical spinal cord have been reported much more frequently than lesions of the dorsal spinal cord; lesions of the lumbal spinal cord are a very rare event. There exist different conceptions of the pathogenesis: opinions differ as to whether the effect is primarily on the connective tissue and blood vessels or on nerve cells and their axons or if the different tissues are injured simultaneously; moreover an autoimmuno-hypothesis is discussed. The clinical signs of radiation myelopathy can be grouped into two major syndromes: the transient radiation myelopathy and the delayed or chronic radiation myelopathy, which usually develops gradually with a subsequent chronic progressive course but in some cases may occur acutely after the latent period; the course is not always progressive but may be undulating and remissions have been reported in some rare cases...
本文对有关放射性脊髓病的文献进行了综述。需注意以下几点:放射性脊髓病是脊柱外肿瘤放射治疗中一种罕见的并发症,不过在过去几年中病例报告数量不断增加;这可能归因于高能治疗的使用日益增多。脊髓剂量达到1000拉德就可能有危险;随着剂量增加,放射性脊髓病的风险也在上升。除了总剂量外,放射性脊髓病的发生率还取决于剂量率、总的给药时间、单次分割剂量大小、照射野大小、受照射体积大小、照射类型、高压氧的使用以及一些其他特殊的放射条件。但放射性脊髓病的发生率不仅取决于放射技术,还取决于患者的个体差异。放射敏感性的个体差异是一个众所周知的事实;这可能部分归因于内在的生物学反应差异。此外,同时存在的疾病——尤其是高血压——以及可能同时服用的某些药物可能会加剧放射性脊髓病的发生率。似乎不存在与年龄、性别和原发肿瘤类型的相关性。颈段脊髓的放射性损伤报告比胸段脊髓损伤更为频繁;腰段脊髓损伤则极为罕见。对于发病机制存在不同观点:关于其作用主要是针对结缔组织和血管还是神经细胞及其轴突,或者不同组织是否同时受损,存在不同看法;此外,还讨论了自身免疫假说。放射性脊髓病的临床症状可分为两大综合征:短暂性放射性脊髓病和迟发性或慢性放射性脊髓病,后者通常逐渐发展并随后呈慢性进行性病程,但在某些情况下可能在潜伏期后急性发作;病程并非总是进行性的,可能呈波浪式,并且在一些罕见病例中已有缓解的报告……